SCHEMBL569758

SCHEMBL569758

NS(=O)(=O)c1ccccc1Oc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.55
CA2 P00918 10/20 0.50
CA1 P00915 9/20 0.50
CA9 Q16790 8/20 0.50
CA12 O43570 6/20 0.49
CASP1 P29466 1/20 0.48
CA7 P43166 3/20 0.47
CA13 Q8N1Q1 1/20 0.47
CTNNB1 P35222 1/20 0.47
CA6 P23280 3/20 0.47
CA4 P22748 2/20 0.47
CA14 Q9ULX7 2/20 0.47
CA5A P35218 2/20 0.47
CA5B Q9Y2D0 2/20 0.47
CYP2C9 P11712 1/20 0.47
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 1/20 0.46
P2RX4 Q99571 1/20 0.44
PTGS2 P35354 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10529086 0.87 CA2 (0.54) SOS1CA2CA1CA9CA12
SCHEMBL3877575 0.85 CASP1 (0.51) SOS1CA2CA1CA9CA12
SCHEMBL10865382 0.85 PTGES2 (0.57) SOS1CA2CA1CA9CA12
SCHEMBL15258942 0.84 SOS1 (0.47) SOS1CA2CA1CA9CA12
SCHEMBL502864 0.83 CASP1 (0.50) SOS1CA2CA1CA9CASP1
SCHEMBL146565 0.83 CASP1 (0.50) SOS1CA2CA1CA9CASP1
SCHEMBL11599660 0.82 CASP1 (0.49) SOS1CA2CA1CA9CASP1
Ammonia Solution, Strong SCHEMBL502557 0.82 CASP1 (0.49) SOS1CA2CA1CA9CASP1
SCHEMBL4657647 0.81 CA12 (0.55) SOS1CA2CA1CA9CA12
SCHEMBL10865180 0.81 CASP1 (0.55) SOS1CA2CA1CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2393495-B1 CARBAMOYLPHOSPHONATES AS INHIBITORS AND USES THEREOF YISSUM RES DEV CO (IL) 2014-07-23 EP claimed
US-20120035140-A1 CARBAMOYLPHOSPHONATES AS INHIBITORS AND USES THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) 2012-02-09 US claimed
EP-2393495-A1 CARJBAMOYLPHOSPHONATES AS INHIBITORS AND USES THEREOF Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. (IL) 2011-12-14 EP claimed
WO-2010089752-A1 CARJBAMOYLPHOSPHONATES AS INHIBITORS AND USES THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) 2010-08-12 WO claimed
WO-2010039911-A1 CALCILYTIC COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-04-08 WO claimed
CN-1103866-A Nes pesticides RHONE POULENC AGRICULTURE (GB) 1995-06-21 CN claimed
EP-0634404-A1 Phtalazin derivatives and their use as pesticides RHONE POULENC AGRICULTURE LTD. (GB) 1995-01-18 EP claimed
EP-0148755-B1 2-PHENOXY-PHENYLSULFONYLISOCYANATE NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1986-11-20 EP claimed
EP-0148755-A2 2-Phenoxy-phenylsulfonylisocyanate NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1985-07-17 EP claimed
US-20260062393-A1 Compounds CTXT PTY LTD (AU) 2026-03-05 US disclosed
US-12365655-B2 Compounds CTXT PTY LTD (AU) 2025-07-22 US disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
US-9206130-B2 Quinoline derivatives as AXL kinase inhibitors MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2015-12-08 US disclosed
US-8993544-B2 Carbamoylphosphonates as inhibitors and uses thereof YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) 2015-03-31 US disclosed
EP-0148755-A2 2-Phenoxy-phenylsulfonylisocyanate NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1985-07-17 EP disclosed
EP-0148755-A2 2-Phenoxy-phenylsulfonylisocyanate NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1985-07-17 EP disclosed
US-4514213-A Herbicidal sulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-04-30 US disclosed
US-4500342-A Herbicidally active substituted phenylsulfonylurea derivatives and intermediates therefor NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1985-02-19 US disclosed
EP-0129764-A2 Substituted phenylsulfonyl guanidine derivatives NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1985-01-02 EP disclosed
EP-0056969-A2 Substituted derivatives of phenylsulfonyl urea, process and intermediates for their preparation and herbicidal compositions containing the derivatives NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1982-08-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035140-A1 CARBAMOYLPHOSPHONATES AS INHIBITORS AND USES THEREOF MMP9, MMP26, MMP25 SOS1 3731/4885CA2 91/4885CA1 247/4885
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 SOS1 2530/4885CA2 255/4885CA1 881/4885
US-20260062393-A1 Compounds SCN2B, ABCB11, SCN1B SOS1 4066/4885CA2 199/4885CA1 1778/4885
US-12365655-B2 Compounds SLC10A1, ABCB11, PCSK9 SOS1 2526/4885CA2 256/4885CA1 881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.